News and Announcements
Invest in ASX shares $8 per trade
- Published October 10, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Did you know that an established online broker has started to offer investment services at some of the lowest costs you can find in Australia?
ThinkMarkets, the Australian regulated broker with 10 years in the industry, is proud to offer Australian shares and ETFs listed on the ASX and Chi-X with a flat fee of just $8 per trade.
With no hidden fees or monthly subscription fees all your investing is secure with your direct ownership on your individual HIN.
And all that on ThinkTrader, a next-generation mobile app that delivers all the analysis tools you need to trade on the go; available exclusively to ThinkMarkets investors.
Sign up for an investing account today via the ThinkTrader app.
To learn more about investing in Australian shares with ThinkMarkets, visit their website.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
